Cargando…
New immunopathologic insights into multiple sclerosis
Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of the central nervous system. Although the immune system seems to play an important role in the pathogenesis of disease, target antigens are still uncertain and pathways leading to tissue destruction have not been fully elu...
Autores principales: | Hemmer, Bernhard, Kieseier, Bernd, Cepok, Sabine, Hartung, Hans-Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Current Medicine Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088761/ https://www.ncbi.nlm.nih.gov/pubmed/12691630 http://dx.doi.org/10.1007/s11910-003-0085-y |
Ejemplares similares
-
Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine
por: Warnke, Clemens, et al.
Publicado: (2010) -
HLA-DRB1(∗)0401 and HLA-DRB1(∗)0408 Are Strongly Associated with the Development of Antibodies against Interferon-β Therapy in Multiple Sclerosis
por: Hoffmann, Steve, et al.
Publicado: (2008) -
Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis
por: Warnke, Clemens, et al.
Publicado: (2011) -
Review of teriflunomide and its potential in the treatment of multiple sclerosis
por: Warnke, Clemens, et al.
Publicado: (2009) -
Sequencing the immunopathologic heterogeneity in multiple sclerosis
por: Antel, Jack P, et al.
Publicado: (2015)